| BCBS Federal Medical & Drug | 5.21.156 Monjuvi (tafasitamab-cxix) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.21.160 Xeloda (capecitabine) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.21.161 Onureg (azacitidine) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.21.162 Gavreto (pralsetinib) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.21.164 Danyelza (naxitamab-gqgk) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.21.165 Margenza (margetuximab-cmkb) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.21.167 Tepmetko (tepotinib) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.21.169 Breyanzi (lisocabtagene maraleucel) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.21.170 Cosela (trilaciclib) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.21.172 Fotivda (tivozanib) | 2026-03-06 |